Valley Cottage, NY, July 28, 2016 --(PR.com
)-- An Auto-injector is a pen shaped medical device designed to deliver a dose of a particular drug. These devices are mostly used to during serious allergic reaction i.e. anaphylaxis. Most auto-injectors are available as pre-filled syringes. Auto-injectors are intended for self-administration by patients, or administration by any personnel at home. The site of injecting the drug depends on the nature of the drug, but usually taken through an intramuscular route. The syringe needle is inserted at the site of injection with the push of a button and the drug gets delivered. Auto-injectors are basically designed to overcome the reluctance associated with self-administration of intramuscular injections.
Auto-injectors market comprises of the auto-injector devices generally used for treatment of anaphylaxis, multiple sclerosis, rheumatoid arthritis and others.
The main factor driving the growth of auto-injectors market is the increasing incidence of anaphylactic shock, whereas other factors includes increasing patient awareness regarding these devices and inclination of the patients to opt for self-administration of injections. Also, the growth of auto-injectors market is attributed to government approval for marketing the device in different regions. Secondly increased usage of the device for severe pain also drives the market for auto-injectors. However apart from the factors leading to the growth of this market, there are some restraints hampering the market growth over the forecast period for example high pricing of these injectors and substitute products like general injections and oral tablets restricts the market growth over the forecast period.
Request Free Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-1642
The Auto-injector market is segment based on the product type, application and distribution type
Auto-injectors market is segmented into following types:
Other Emergency Condition
Auto-injectors market is expected to grow at a significant rate, over the forecast period. The market is anticipated to perform well over the forecast period due to increasing number of patients for anaphylaxis treatment and increasing awareness regarding prefilled self-administration injections. Secondly the auto-injectors market is expanding globally due to rising geriatric population and increasing incidence of diseases. The disposable auto-injectors are expected to grow with a decent CAGR over the forecast period. Increasing competition among the manufacturers of auto-injectors tend to drive auto-injectors market towards the growth curve.
On the basis of region presence, the auto-injectors market is segmented into five key regions: North America, Latin America, Europe, Asia Pacific, and Middle East & Africa.
Request For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1642
The rapid development in technology, increasing healthcare expenditure and willingness to adopt innovative products for emergency care and chronic & acute diseases are some of the key factors projected to drive the growth of auto-injectors market globally during the forecast period. North America holds a major share of market and it is expected to grow with a healthy CAGR over the forecast period, due to increased government spending and greater awareness self-administration of pre-filled syringes. Whereas Asia pacific is projected to grow with the fastest CAGR due to factors such as increased healthcare spending for emergency medical applications and rising number of anaphylaxis cases. Auto-injectors market in Western Europe is also anticipated to grow with a decent CAGR, due to increasing inclination of patients, to opt for self-administered injections.
Main Key market players in the auto-injectors market includes Biogen Idec, Becton, Dickinson & Co., Mylan N.V., Pfizer, Inc., Sanofi, UNILIFE CORPORATION, Scandinavian Health Ltd. and few more. Whereas auto-injectors market is expected to witness entry of local players over the forecast period.